Systemic Lupus Erythematosus - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 409 pages report, published by Global Markets Direct

Report ThumbnailMay-2017
Systemic Lupus Erythematosus - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus - Pipeline Review, H1 2017, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

Systemic lupus erythematosus (SLE) is an autoimmune disease that causes a chronic inflammatory condition. The inflammation triggered by SLE affect many organs in the body, including skin, joints, kidney

Read More
  • List of Figures
  • Number of Products under Development for Systemic Lupus Erythematosus, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Routes of Administrat
Read More
  • List of Tables
  • Number of Products under Development for Systemic Lupus Erythematosus, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017
  • Number of Products under Develo
Read More
  • Table of Contents
  • Table of Contents 2
  • Introduction 6
  • Systemic Lupus Erythematosus - Overview 7
  • Systemic Lupus Erythematosus - Therapeutics Development 8
  • Systemic Lupus Erythematosus - Therapeutics Assessment 24
  • Systemic Lupus Erythematosus - Companies Involved in Therapeutics Development 38
  • Systemic Lupus Erythematosus - Drug Profiles 78
  • Systemic Lupus Erythematosus - Dormant Projects 379
  • Systemic Lupus Erythematosus - Discontinued Products 384
  • Systemic Lupus Erythematosus - Product Development
Read More

Please select a license type

Share

Related Products

Global Markets DirectSystemic Lupus Erythematosus - Pipeline Review, H1 2017Product ThumbnailSystemic Lupus Erythematosus - Pipeline Review, H1 2017, Industry ReportProduct #: 797273
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved